Find therapies in clinical trials near you – page 57

Study on Regorafenib and Nivolumab for Patients with Advanced Gastro-Oesophageal Cancer

Study on Regorafenib and Nivolumab for Patients with Advanced Gastro-Oesophageal Cancer

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Study on the Effectiveness of Mesenchymal Stromal Cells in Children with Steroid-Refractory Acute Graft-Versus-Host Disease

Study on the Effectiveness of Mesenchymal Stromal Cells in Children with Steroid-Refractory Acute Graft-Versus-Host Disease

Study Comparing Atogepant and Topiramate for Preventive Treatment in Adults with Migraine

Study Comparing Atogepant and Topiramate for Preventive Treatment in Adults with Migraine

Study of LY3502970 for Adults with Obesity or Overweight and Type 2 Diabetes

Study of LY3502970 for Adults with Obesity or Overweight and Type 2 Diabetes

Study on Rituximab and Drug Combination for Treating Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents

Study on the Effects of GS-5290 for Patients with Moderate to Severe Ulcerative Colitis

Study on the Effects of GS-5290 for Patients with Moderate to Severe Ulcerative Colitis

Study of GS-5718 for Patients with Cutaneous Lupus Erythematosus (CLE)

Study of GS-5718 for Patients with Cutaneous Lupus Erythematosus (CLE)

Study on the Effects of MBS2320 for Patients with Idiopathic Pulmonary Fibrosis (IPF)

Study on the Effects of MBS2320 for Patients with Idiopathic Pulmonary Fibrosis (IPF)

Study Comparing Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low-Risk Myelodysplastic Syndrome Who Are Not Dependent on Blood Transfusions

Study Comparing Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low-Risk Myelodysplastic Syndrome Who Are Not Dependent on Blood Transfusions

Study on the Safety and Effects of Favezelimab and Pembrolizumab for Patients with Blood Cancers

Study on the Safety and Effects of Favezelimab and Pembrolizumab for Patients with Blood Cancers